Global Facial Aesthetics Devices (2020 to 2027) - Market Trajectory & Analytics apnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from apnews.com Daily Mail and Mail on Sunday newspapers.
Parcel near Route 128 rezoned in Needham
Updated May 4, 2021, 7:11 p.m.
Email to a Friend
Needham votes to rezone land overlooking Route 128
Needham Town Meeting voters overwhelmingly approved a zoning change for 15 acres along Highland Avenue, overlooking Route 128. The change for the properties, currently home to two Muzi auto dealerships and the WCVB-TV studio, has been in the works for years. A previous version failed to receive the two-thirds majority it needed in 2019. This time, on Monday, Town Meeting voters resoundingly backed it, 168-37, The proponents scaled back what would be allowed there in terms of size, compared to the 2019 version, and also allowed for up to 240 residential units, a new addition. This new zoning would allow up to 870,000 square feet of development in total, with a maximum building height of four stories. The zoning would allow for apartments as well as a number of commercial uses but has been deliberately designed to exclude warehouses, which are
Karyopharm Announces the Appointment of Richard Paulson as President and Chief Executive Officer Richard Paulson, Recent Chief Executive Officer of Ipsen North America and Former Vice President and General Manager of Oncology at Amgen, Brings Wealth of Commercial Leadership and Global Strategic Experience Michael G. Kauffman to Remain on Board of Directors and Assume New Role as Senior Clinical Advisor
News provided by
Share this article
Share this article
NEWTON, Mass., May 3, 2021 /PRNewswire/ Karyopharm Therapeutics Inc. (Nasdaq:KPTI), a commercial-stage pharmaceutical company pioneering novel cancer therapies, today announced the appointment of Richard Paulson as Karyopharm s President and Chief Executive Officer, effective May 3, 2021. Mr. Paulson will also remain a member of the Board of Directors. He will succeed Michael G. Kauffman, MD, PhD, as Chief Executive Officer and Sharon Shacham, PhD, MBA, as President. Dr. Kauffman will continue in his role as a member
Karyopharm Reports First Quarter 2021 Financial Results and Highlights Recent Company Progress Total Revenues of $23.3 Million for the First Quarter of 2021; XPOVIO® (selinexor) Net Product Sales of $21.7 Million Conditional Marketing Authorization Granted by the European Commission for NEXPOVIO® (selinexor) in Penta-Refractory Multiple Myeloma; European Decision for Expanded Multiple Myeloma Indication Expected in the Fourth Quarter of 2021 Richard Paulson Appointed Next President and Chief Executive Officer of Karyopharm Conference Call Scheduled for Today at 8:30 a.m. ET
News provided by
Share this article
Share this article
NEWTON, Mass., May 3, 2021 /PRNewswire/ Karyopharm Therapeutics Inc. (Nasdaq:KPTI), a commercial-stage pharmaceutical company pioneering novel cancer therapies, today reported financial results for the quarter ended March 31, 2021. In addition, Karyopharm highlighted select corporate milestones, including details regarding the appo
Karyopharm Announces the Appointment of Richard Paulson as President and Chief Executive Officer prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.